IMAX Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 100.33 M

IMAX Corporation EBITDA is USD 100.33 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -13.17% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • IMAX Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 115.55 M, a 58.82% change year over year.
  • IMAX Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 72.76 M, a 1.45% change year over year.
  • IMAX Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 71.72 M, a -310.46% change year over year.
  • IMAX Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -34.08 M, a -141.04% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)